This federal contract award was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of RINVOQ ER 15 MG TABLET UU 30S. The contract has a ceiling value of $11,122.87 and an ultimate completion date of July 19, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen Drug Corp is the prime contractor, and the contract is associated with the company's Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of RINVOQ ER 15 MG TABLET, a pharmaceutical product. The contract has a ceiling value of $35,203.25 and an ultimate completion date of October 16, 2024. The contract is a firm fixed-price delivery order, and there is no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor responsible for providing the requested medication...
This is a federal contract award with the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,835.82, is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of November 26, 2024. This award is not associated with a set-aside designation....
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $57,280.05, is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of February 25, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,202.34, is for the supply of RINVOQ ER 45 MG TABLET UU 28S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of January 29, 2025. The award is not associated with a set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,771.36, is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. It is a Firm Fixed Price Delivery Order contract with a completion date of February 24, 2025. The contract is not set aside for any specific business type. Amerisourcebergen holds a significant Indefinite...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product, with a ceiling value of $19,567.11 and a completion date of July 19, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,547.87, is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract has a completion date of March 31, 2025 and is a firm fixed-price delivery order. The award is not associated with any set-aside requirements. AmerisourceBergen Drug Corp is the prime...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the pharmaceutical product RINVOQ ER 15 MG TABLET UU 30S. The contract has a ceiling value of $69,390.71 and a completion date of January 23, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor and has an Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a $18,046.26 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of the pharmaceutical product RINVOQ ER 15 MG TABLET, with a completion date of September 24, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing this product through an Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for...